Expert suggestion for pituitary disease management during the recent COVID-19 pandemic

doi:10.16150/j.1671-2870.2022.02.004

Abstract

CLC Number:

R584

Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for pituitary disease management during the recent COVID-19 pandemic[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 130-132.

References 7

[7]	Chinese pituitary adenoma cooperation group. Consensus of Chinese experts on diagnosis and treatment of Cushing′s disease(2015)[J]. Natl Med J China, 2016, 96(11):835-840.
[8]	Pivonello R, Ferrigno R, Isidori AM, et al. COVID-19 and Cushing′s syndrome: recommendations for a special population with endogenous glucocorticoid excess[J]. Lancet Diabetes Endocrinol, 2020, 8(8):654-656. doi: 10.1016/S2213-8587(20)30215-1 URL
[9]	Newell-Price J, Nieman LK, Reincke M, et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing′s syndrome[J]. Eur J Endocrinol, 2020, 183(1):G1-G7. doi: 10.1530/EJE-20-0352 URL
[10]	王卫庆, 单忠艳, 王广, 等. 新型冠状病毒肺炎疫情期间糖尿病基层管理专家建议[J]. 中华内分泌代谢杂志, 2020, 36(3):185-190.
	Wang WQ, Shan ZY, Wang G, et al. Expert advice on diabetes management at the grass-roots level during the outbreak of novel coronavirus pneumonia[J]. Chin J Endocrinol Metab, 2020, 36(3):185-190.
[11]	中国医师协会内分泌代谢科医师分会, 中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(1):1-10.
	Endocrinologist branch of Chinese Medical Association, Chinese inpatient blood glucose management expert group. Consensus of Chinese inpatient blood glucose management experts[J]. Chin J Endocrinol Metab, 2017, 33(1):1-10.
[12]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4):311-398.
	Diabetes branch of Chinese Medical Association. Guidelines for prevention and treatment of type 2 diabetes in China (2020 Edition)[J]. Chin J Endocrinol Metab, 2021, 37(4):311-398.
[13]	中华医学会内分泌学分会肥胖学组. 肾上腺皮质功能减退症患者围手术期糖皮质激素管理专家共识[J]. 中华内分泌代谢杂志, 2022, 38(1):1-6.
[1]	Yuen KCJ, Blevins LS Jr, Findling JW. Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic[J]. Endocr Pract, 2020, 26(8):915-922. doi: 10.4158/EP-2020-0308 URL
[2]	Fleseriu M, Dekkers OM, Karavitaki N. Endocrinology in the time of COVID-19: Management of pituitary tumours[J]. Eur J Endocrinol, 2020, 183(1):G17-G23. doi: 10.1530/EJE-20-0473 URL
[3]	Fleseriu M, Buchfelder M, Cetas JS, et al. Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective[J]. Pituitary, 2020, 23(4):327-337. doi: 10.1007/s11102-020-01059-7 pmid: 32556793
[4]	Christ-Crain M, Hoorn EJ, Sherlock M, et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia[J]. Eur J Endocrinol, 2020, 183(1):G9-G15. doi: 10.1530/EJE-20-0338 URL
[5]	中华医学会内分泌学分会. 肢端肥大症诊治中国专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36(9):751-760.
	Endocrinology branch of Chinese Medical Association. Chinese expert consensus on acromegaly diagnosis and treatment(2020 Edition)[J]. Chin J Endocrinol Metab, 2020, 36(9):751-760.
[6]	中国垂体腺瘤协作组. 中国肢端肥大症诊治共识(2021版)[J]. 中华医学杂志, 2021, 101(27):2115-2126.
	Chinese pituitary adenoma cooperation group. Consensus on diagnosis and treatment of acromegaly in China (2021 Edition)[J]. Natl Med J China, 2021, 101(27):2115-2126.
[13]	Obesity group, endocrinology branch, Chinese Medical Association. Expert consensus on perioperative glucocorticoid management in patients with adrenocortical insufficiency[J]. Chin J Endocrinol Metab, 2022, 38(1):1-6.
[7]	中国垂体腺瘤协作组. 中国库欣病诊治专家共识(2015)[J]. 中华医学杂志, 2016, 96(11):835-840.

Expert suggestion for pituitary disease management during the recent COVID-19 pandemic

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 7

Related Articles 12

Recommended Articles

Metrics

Comments

[1]	SHI Feng, GUO Zhuying, GUO Haiyan. Clinical significance of changes in peripheral blood lymphocyte subsets in patients with novel coronavirus pneumonia [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 619-624.
[2]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestions on the management of hyperthyroidism and hypothyroidism in the time of COVID-19 [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 128-129.
[3]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for osteoporosis management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 133-135.
[4]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for diabetes management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 136-138.
[5]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for adrenal diseases management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 139-142.
[6]	CHEN Changqiang, MENG Jun, JIN Peipei, DAI Jing, et al . Practice and exploration of novel coronavirus nucleic acid detection in designated hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 143-149.
[7]	ZHUANG Lei, ZHENG Ruizhi, GAO Weiyi, et al . Analysis on the epidemic situation of COVID-19 by Omicron variant in a single office building [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 150-153.
[8]	ZHANG Feng, YANG Jing, YAN Yue, CHEN Weihong, CAI Zhengyu, LIU Xiying, CHENG Jie, WAN Jin, XI Jing, YANG Zhitao, QIU Liping, CHEN Erzhen. Analysis and suggestions on petition status of Fangcang and designated hospitals during COVID-19 epidemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 160-164.
[9]	ZHANG Yibo, WU Wenjuan, BI Yufang, JING Feng, GU Zhidong, YANG Zhitao, SHANG Hanbing, LIN Jingsheng, CHEN Erzhen. Construction and practice of infection prevention and control system in large Fangcang shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 165-168.
[10]	LOU Jiao, JIANG Lingli, WANG Yin, ZHOU Jing, HU Xiaobo, WANG Qing, et al . Exploration of quality control methods for regional COVID-19 nucleic acid detection laboratories [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 174-177.
[11]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[12]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.